Knoll Capital group discloses 5.3% Elicio Therapeutics stake (ELTX)

Rhea-AI Filing Summary

Elicio Therapeutics ownership update: Knoll Capital Management, Fred Knoll and Gakasa Holdings amended their Schedule 13G/A to report beneficial ownership of 1,211,957 shares of Common Stock, representing 5.3% of the class. The filing shows shared voting and shared dispositive power for the same amount.

Insights

Corporate Governance Analyst

Passive 13G filing signals a disclosed >5% stake with shared control.

This amendment reports 1,211,957 shares (5.3%) held with shared voting and dispositive power. The filing names Knoll Capital Management, Fred Knoll and Gakasa Holdings as reporting persons and documents their roles.

Materiality is procedural: this is a disclosure of position size and authority; subsequent filings would be required for active changes. Timing and cash-flow treatment are not specified in the excerpt.

Investor Relations Advisor

Holders cross 5% threshold requiring public disclosure; no transaction details provided.

The Schedule 13G/A amendment lists the address and CUSIP 28657F103, and indicates shared powers over the disclosed shares. It does not state purchase dates, purchases, or sale plans in this excerpt.

Future filings could clarify acquisition timing or intent; until then, the disclosure is a static ownership snapshot.

Key Figures

Beneficial ownership: 1,211,957 shares Percent of class: 5.3% CUSIP: 28657F103 +2 more

5 metrics

Beneficial ownership 1,211,957 shares Reported on Schedule 13G/A amendment

Percent of class 5.3% Percent of Common Stock reported

CUSIP 28657F103 Elicio Therapeutics Common Stock identifier

Shared voting power 1,211,957 shares Amount with shared voting power

Shared dispositive power 1,211,957 shares Amount with shared dispositive power

Key Terms

Schedule 13G/A, Beneficially owned, Shared dispositive power, CUSIP

4 terms

Schedule 13G/A regulatory

"Amendment No. 1 ) Elicio Therapeutics, Inc"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

Beneficially owned financial

"beneficially owns 1,211,957 shares of the Issuer's Common Stock"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Shared dispositive power financial

"Shared Dispositive Power 1,211,957.00"

CUSIP regulatory

"Common Stock, par value $0.01 per share 28657F103"

A CUSIP is a nine-character alphanumeric code that uniquely identifies a U.S. or Canadian financial security—such as a stock, bond, or fund share—like a Social Security number for an investment. It matters to investors because brokers, exchanges and record-keepers use the CUSIP to match trades, track ownership, settle transactions and pull accurate records, reducing errors and ensuring money and securities go to the right place.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/08/2026 - 02:18 PM Accepted by SEC EDGAR 07/08/2026 - 02:18 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

Elicio Therapeutics, Inc

(Name of Issuer)

Common Stock, par value $0.01 per share

(Title of Class of Securities)

28657F103

(CUSIP Number)

07/01/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 28657F103

1

Names of Reporting Persons

Knoll Capital Management, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

FLORIDA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,211,957.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,211,957.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,211,957.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.3 %

12

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person: LLC

SCHEDULE 13G

CUSIP Number(s): 28657F103

1

Names of Reporting Persons

Fred Knoll

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,211,957.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,211,957.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,211,957.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.3 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

CUSIP Number(s): 28657F103

1

Names of Reporting Persons

Gakasa Holdings, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,211,957.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,211,957.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,211,957.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.3 %

12

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person: Gakasa Holdings, LLC beneficially owns 1,211,957 shares of the Issuer's Common Stock. Knoll Capital Management has trading authority for Gakasa, and Fred Knoll is the President of Knoll Capital Management, LLC.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Elicio Therapeutics, Inc
(b)	Address of issuer's principal executive offices: 451 D Street, 5th Floor Boston, MA, 02210
Item 2.
(a)	Name of person filing: Knoll Capital Management, LLC. Fred Knoll. Gakasa Holdings LLC.
(b)	Address or principal business office or, if none, residence: 201 S. Biscayne Blvd suite 800, Miami, FL 33131
(c)	Citizenship: USA
(d)	Title of class of securities: Common Stock, par value $0.01 per share
(e)	CUSIP No.: 28657F103
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 1,211,957
(b)	Percent of class: 5.3%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 1,211,957
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 1,211,957
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Knoll Capital Management, LLC

Signature:	Fred Knoll
Name/Title:	President
Date:	07/07/2026

Fred Knoll

Signature:	Fred Knoll
Name/Title:	Fred Knoll
Date:	07/07/2026

Gakasa Holdings, LLC

Signature:	Fred Knoll
Name/Title:	By, Knoll Capital Management LLC, President
Date:	07/07/2026